ShiraTronics was created to be the world's leading provider of innovative therapy for migraine headaches. The company is focused on developing and clinically testing its neuromodulation technology. The company was spun off from NuXcel, an electrical medical device focused accelerator. The leadership team of ShiraTronics has overseen the development of active implantable devices and brought them to the market over last 30 years.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/26/20 | $3,000,000 | Series A |
Breakout Ventures | undisclosed |
| 10/09/24 | $66,000,000 | Series B |
Amzak Health Aperture Venture Partners Global BioAccess Fund Norwest Venture Partners  OSF Ventures Seroba Life Sciences Treo Ventures U.S. Venture Partners | undisclosed |
